期刊文献+
共找到53篇文章
< 1 2 3 >
每页显示 20 50 100
Therapeutic and Medicinal Uses of <i>Aloe vera</i>: A Review 被引量:5
1
作者 Pankaj K. Sahu Deen Dayal Giri +5 位作者 Ritu Singh Priyanka Pandey Sharmistha Gupta Atul Kumar Shrivastava Ajay Kumar Kapil Dev Pandey 《Pharmacology & Pharmacy》 2013年第8期599-610,共12页
The plant Aloe vera is used in Ayurvedic, Homoeopathic and Allopathic streams of medicine, and not only tribal community but also most of the people for food and medicine. The plant leaves contains numerous vitamins, ... The plant Aloe vera is used in Ayurvedic, Homoeopathic and Allopathic streams of medicine, and not only tribal community but also most of the people for food and medicine. The plant leaves contains numerous vitamins, minerals, enzymes, amino acids, natural sugars and other bioactive compounds with emollient, purgative, anti-microbial, anti inflammatory, antioxidant, aphrodisiac, anti-helmenthic, antifungal, antiseptic and cosmetic values for health care. This plant has potential to cure sunburns, burns and minor cuts, and even skin cancer. The external use in cosmetic primarily acts as skin healer and prevents injury of epithelial tissues, cures acne and gives a youthful glow to skin, also acts as extremely powerful laxative. 展开更多
关键词 ALOE vera Antimicrobial therapeutic MEDICINAL uses Cosmetic Application
下载PDF
Design,delivery and efficacy testing of therapeutic nucleic acids used to inhibit hepatitis C virus gene expression in vitro and in vivo 被引量:9
2
作者 Wolfgang H.Caselmann Matthias Serwe +3 位作者 Thomas Lehmann János Ludwig Brian S.Sproat Joachim W.Engels 《World Journal of Gastroenterology》 SCIE CAS CSCD 2000年第5期626-629,共4页
Despite major achievements in the treatment ofchronic hepatitis C with the combination ofinterferons and the nucleoside analog ribavirin themajority of patients with chronic hepatitis C virus(HCV) infection cannot be ... Despite major achievements in the treatment ofchronic hepatitis C with the combination ofinterferons and the nucleoside analog ribavirin themajority of patients with chronic hepatitis C virus(HCV) infection cannot be treated effectively.Toimprove this response rate we used antisensetechnologies to inhibit HCV translation as possibleadditional option for experimental treatment.Antisense oligodeoxynucleotides(ODN) are 展开更多
关键词 hepatitis C-like viruses/therapy gene expression in VITRO in vivo nucleic acids/therapeutic use CYTOMEGALOVIRUS
下载PDF
Blastocystis hominis as a cause of chronic diarrhea in low-resource settings:A systematic review
3
作者 Stephen Amoak Jonathan Soldera 《World Journal of Meta-Analysis》 2024年第3期30-41,共12页
BACKGROUND Blastocystis hominis(B.hominis),an anaerobic unicellular protist parasite,is known for its diverse clinical manifestations upon infecting the human gastrointestinal tract.Although globally distributed,it is... BACKGROUND Blastocystis hominis(B.hominis),an anaerobic unicellular protist parasite,is known for its diverse clinical manifestations upon infecting the human gastrointestinal tract.Although globally distributed,it is particularly prevalent in developing nations.Examining the symptoms and treatment outcomes of B.hominis infection in low-resource settings holds immense significance,providing healthcare practi-tioners with valuable insights to enhance patient care.AIM To synthesize existing evidence on the symptomatology and treatment outcomes of B.hominis infection in low-resource settings.METHODS Following the Preferred Reporting Items for Systematic Review and Meta-Analysis guidelines,a systematic review was conducted.The search spanned electronic databases including PubMed,Scopus,and Google Scholar.After a comprehensive screening process,a thorough examination of the papers,adhering to inclusion and exclusion criteria,and data extraction from eligible studies was conducted.The findings underwent summarization through simple descriptive analysis.RESULTS The search yielded 1200 papers,with 17 meeting inclusion criteria.Chronic diarrhea due to B.hominis infection was reported in only two studies,while abdominal pain,diarrhea,flatulence,constipation,and nausea/vomiting emerged as the most commonly documented symptoms.Recovery rates after one week of treatment ranged from 71.8%to 100%,and after two weeks,from 60%to 100%.CONCLUSION In low-resource settings,chronic diarrhea resulting from B.hominis infection is infrequent.Common symptoms include abdominal pain,diarrhea,flatulence,constipation,and nausea/vomiting.Post-treatment,clinical outcomes are notably favorable,supporting the recommendation for treatment.Metronidazole is advocated as the first-line agent,with consideration for switching to a second-line option in cases of treatment failure or poor response. 展开更多
关键词 Blastocystis infections Gastrointestinal diseases Treatment outcome Developing countries Metronidazole/therapeutic use
下载PDF
Continuous Wear of Hydrogel Contact Lenses for Therapeutic Use
4
作者 Daisuke Kudo Hiroshi Toshida +1 位作者 Toshihiko Ohta Akira Murakami 《Open Journal of Ophthalmology》 2012年第4期110-113,共4页
Purpose: To investigate the efficacy and complications of continuous wear of etafilcon A for therapeutic use. Materials and Methods: The subjects were 228 eyes of 219 outpatients prescribed contact lens (CL) for one w... Purpose: To investigate the efficacy and complications of continuous wear of etafilcon A for therapeutic use. Materials and Methods: The subjects were 228 eyes of 219 outpatients prescribed contact lens (CL) for one week of continuous therapeutic wear during 10 years. The reason for prescription of CLs, the primary disease, the duration of CL wear and the complications were assessed retrospectively. Results: The predominant reason for prescription of CLs was relief of pain or a foreign-body sensation (62.3%) and protection of the corneal epithelium (20.6%). The primary disease was post-penetrating keratoplasty (36.8%), followed by corneal epithelial erosion (14.5%), post-lamellar keratoplasty (14.0%) and bullous keratopathy (12.2%). The average duration of wearing single lens was 6.5 ± 3.2 days. The average duration of wearing CLs in total was 9.2 ± 10.7 months. The most frequent problem associated with continuous wear of CLs was their dropping out of CLs (12.3%). The complications associated with CLs included conjunctivitis with papillary hyperplasia, corneal erosion and superficial punctate keratitis, but corneal ulcer and corneal infiltrates were not found. Conclusion: Serious complications were not shown changing the lenses every week to keep to the prescribed time limit for continuous therapeutic wear, even if corneal epithelial barrier function is impaired. 展开更多
关键词 therapeutic use BANDAGE Soft Contact LENS CONTINUOUS WEAR COMPLICATION
下载PDF
Clinacanthus nutans:a review of the medicinal uses,pharmacology and phytochemistry 被引量:10
5
作者 Md.Ariful Alam Sahena Ferdosh +4 位作者 Kashif Ghafoor Md.Abdul Hakim Abdul Shukor Juraimi Alfi Khatib Md.Zaidul I.Sarker 《Asian Pacific Journal of Tropical Medicine》 SCIE CAS 2016年第4期393-399,共7页
Clinacanthus nutans Lindau is known as snake grass belonging to the Acanlhaceae family.This plant has diverse and potential medicinal uses in traditional herbal medicine for treating skin rashes,insects and snake bite... Clinacanthus nutans Lindau is known as snake grass belonging to the Acanlhaceae family.This plant has diverse and potential medicinal uses in traditional herbal medicine for treating skin rashes,insects and snake bites,lesions caused by herpes simplex virus,diabetes,and gout in Malaysia.Indonesia.Thailand and China.Phylochemieal investigations documented the varied contents of bioaclive compounds from litis plant namely flavonoids,glycosides,glycoglyeerolipids.cerebrosides and monoacylmonogalatosylglycerol.The pharmacological experiment proved that various types of extracts and pure compounds from this species exhibited a broad range of biological properties such as anti-inflammatory,antiviral,antioxidant,and anti-diabetic activities.The lindings of toxicity study showed that extracts from this plant did not show any toxicity thus it can be used as strong therapeutic agents for specific diseased conditions.However,further experiments on chemical components and their mode of action showing biological activities are required to elucidate the complete phytochemical profile and assess to confirm their suitability tor future drugs.This review summarizes the medicinal uses,phytochemistry and pharmacology of this plant in order to explore its therapeutic potential and gaps necessitating for prospected research work. 展开更多
关键词 Clinacanthus nutans MEDICINAL uses PHYTOCHEMICALS PHARMACOLOGY therapeutic potential
下载PDF
Comparison of long-lasting therapeutic effects between succimer and penicillamine on hepatolenticular degeneration 被引量:3
6
作者 REN Ming Shan, ZHANG Zhi, WU Jun Xia, LI Fei, XUE Ben Chun and YANG Ren Min 《World Journal of Gastroenterology》 SCIE CAS CSCD 1998年第6期75-77,共3页
AIM To compare the long term effect of succimer (Suc) with that of penicillamine (Pen) in treating hepatolenticular degeneration (HLD). METHODS One hundred and twenty patients with HLD were divided into 2 groups. ... AIM To compare the long term effect of succimer (Suc) with that of penicillamine (Pen) in treating hepatolenticular degeneration (HLD). METHODS One hundred and twenty patients with HLD were divided into 2 groups. Group A ( n =60) received Suc 750mg , po. bid. Group B ( n =60) received Pen 250mg , po. qid. The period of maintenance treatment varied from 6 months to 3 years, averaging 1 5 years. Symptoms and therapeutic effects were evaluated by modified Goldstein scale. RESULTS The total effectiveness of group A in two different periods of treatment were 80% and 85% respectively, higher than those of group B (58% and 59% respectively) ( P <0 05). Suc also had obvious curative effects for the patients who failed in the use of Pen. There were fewer side effect in group A than in group B ( P <0 05). Suc and Pen could increase urinary copper excretion effectively and continually. CONCLUSION Suc is more effective and safer than Pen. Clinically, it can replace Pen as first choice drug for long term maintenance therapy of HLD. 展开更多
关键词 hepatolenticular degeneration/drug THERAPY succimer/therapeutic use penicillamine/therapeutic use
下载PDF
Functional dyspepsia of ulcer-dysmotility type:clinical incidence and therapeutic strategy 被引量:3
7
作者 WANG XiaoZhong and LIN GuZhen 《World Journal of Gastroenterology》 SCIE CAS CSCD 1998年第4期95-96,共2页
Functionaldyspepsiaofulcerdysmotilitytype:clinicalincidenceandtherapeuticstrategyWANGXiaoZhongandLINGuZhe... Functionaldyspepsiaofulcerdysmotilitytype:clinicalincidenceandtherapeuticstrategyWANGXiaoZhongandLINGuZhenSubjectheaadings... 展开更多
关键词 dyspepsia/drug therapy famotidine/therapeutic use cisapride/therapeutic use peptic ULCER gastrointestinal motility
下载PDF
Therapeutic role of template-based lymphadenectomy in urothelial carcinoma of the upper urinary tract 被引量:5
8
作者 Tsunenori Kondo Toshio Takagi Kazunari Tanabe 《World Journal of Clinical Oncology》 CAS 2015年第6期237-251,共15页
Lymphadenectomy for urothelial carcinoma of the upper urinary tract has attracted the attention of physicians. The mapping study of lymphatic spread has shown that a relatively wide area should comprise the regional n... Lymphadenectomy for urothelial carcinoma of the upper urinary tract has attracted the attention of physicians. The mapping study of lymphatic spread has shown that a relatively wide area should comprise the regional nodes for tumors of the right renal pelvis or the right upper two-thirds of the ureter. A prospective study showed that an anatomical templatebased lymphadenectomy significantly improved patient survival in tumors of the renal pelvis. This benefit was more evident for patients with p T2 stage tumors or higher. The risk of regional node recurrence is significant reduced by template-based lymphadenectomy,which is likely to be associated with improved patient survival. The removal of lymph node micrometastases is assumed to be the reason for therapeutic benefit following lymphadenectomy. The number of resected lymph nodes can be used to assess the quality of lymphadenectomy,but not to determine the extent of lymphadenectomy. The guidelines currently recommend lymphadenectomy for patients with muscle-invasive disease,even though the current recommendation grades are still low. The present limitation of lymphadenectomy is the lack of standardization of the extent of lymphadenectomy and the randomized trials. Further studies are warranted to collect the evidence to support lymphadenectomy. 展开更多
关键词 LYMPHADENECTOMY LYMPH node EXCISION UROTHELIAL carcinoma Treatment outcome therapeutic uses Diagnosis GUIDELINE
下载PDF
Controversies regarding transplantation of mesenchymal stem cells
9
作者 Tsvetelina Velikova Tereza Dekova Dimitrina Georgieva Miteva 《World Journal of Transplantation》 2024年第2期48-61,共14页
Mesenchymal stem cells(MSCs)have tantalized regenerative medicine with their therapeutic potential,yet a cloud of controversies looms over their clinical tran-splantation.This comprehensive review navigates the intric... Mesenchymal stem cells(MSCs)have tantalized regenerative medicine with their therapeutic potential,yet a cloud of controversies looms over their clinical tran-splantation.This comprehensive review navigates the intricate landscape of MSC controversies,drawing upon 15 years of clinical experience and research.We delve into the fundamental properties of MSCs,exploring their unique immuno-modulatory capabilities and surface markers.The heart of our inquiry lies in the controversial applications of MSC transplantation,including the perennial debate between autologous and allogeneic sources,concerns about efficacy,and lingering safety apprehensions.Moreover,we unravel the enigmatic mechanisms surro-unding MSC transplantation,such as homing,integration,and the delicate balance between differentiation and paracrine effects.We also assess the current status of clinical trials and the ever-evolving regulatory landscape.As we peer into the future,we examine emerging trends,envisioning personalized medicine and innovative delivery methods.Our review provides a balanced and informed perspective on the controversies,offering readers a clear understanding of the complexities,challenges,and potential solutions in MSC transplantation. 展开更多
关键词 Mesenchymal stem cells Transplantation controversies Regenerative medicine Autoimmune diseases Chronic inflammatory illnesses Tumor growth METASTASIS therapeutic potential Clinical use of mesenchymal stem cell
下载PDF
High-intensity focused ultrasound extracorporeal ablation of liver tissuesin rabbits
10
《World Journal of Gastroenterology》 SCIE CAS CSCD 1998年第2期16-16,共1页
HighintensityfocusedultrasoundextracorporealablationoflivertissuesinrabbitsCHENGShuQun1,ZHOUXinDa1,TANGZ... HighintensityfocusedultrasoundextracorporealablationoflivertissuesinrabbitsCHENGShuQun1,ZHOUXinDa1,TANGZhaoYou1,YUYao1,B... 展开更多
关键词 LIVER neoplasms experimental/therapy ultrasonic THERAPY iodized oil/therapeutic use liver/radiation effects randomized controlled trials
下载PDF
The role of drug utilization evaluation in medical sciences
11
作者 Ruby Gangwar Arvind Kumar +2 位作者 Abrar Ahmed Zargar Amit Sharma Ranjeet Kumar 《Global Health Journal》 2023年第1期3-8,共6页
Background:Drug utilization evaluation(DUE)is defined by the World Health Organization(WHO)and focuses on the medical,social,and economic consequences of pharmaceutical marketing,distribution,prescribing,and usage in ... Background:Drug utilization evaluation(DUE)is defined by the World Health Organization(WHO)and focuses on the medical,social,and economic consequences of pharmaceutical marketing,distribution,prescribing,and usage in society.The WHO recommends a physician to every 1000 people.According to the recent data from the Health Ministry in 2019,in which 1.16 million doctors are of active population with just 80%,or 0.9 million,practicing.As a result,a ratio of 0.68 doctors for every 1000 people,which is much below as per the WHO reports.This article describes history,types,WHO guidelines,need and purpose of DUE.Objective:The main aim of this paper is to provide information about the rational use of medication in outpa­tient and inpatient department with special emphasis of DUEs.It also provides awareness directly to healthcare professionals,researchers,academicians,pharmacist and nurses to reduce the irrationality of medicines.Methods:The method used to compile this review information gathered from websites,Google scholar,PubMed,Research gate,and studies published on DUE from July 20 to Oct 22 were included as source of information.Results:We studied more than 35 published study on DUE,that reveals most of the physicians prescribed branded drugs not generic drugs,but WHO prescribing indicator allows to prescribe generic drugs in the hospital pharmacy to maintain better inventory control.It may also help to prevent pharmacist misunderstanding during dispensing.Conclusion:The use of generic prescription names avoids the possibility of medication product duplication and lowers patient costs.It is important to remember that incorrect medication prescriptions have impact on both patients and their family members.WHO indicators identify irrational prescribing behaviours to make therapy more rational and cost-effective. 展开更多
关键词 Anatomical therapeutic chemical classification Drug utilization evaluation Prescribing indicators Pregnancy risk classification Rational use of the drug
下载PDF
重复经颅磁刺激联合西酞普兰治疗老年抑郁症的效果观察
12
作者 杜凤英 《中国现代药物应用》 2023年第4期77-79,共3页
目的分析重复经颅磁刺激(r TMS)联合西酞普兰治疗老年抑郁症的临床疗效。方法120例老年抑郁症患者为研究对象,随机分为观察组与对照组,各60例。对照组采用西酞普兰治疗,观察组在对照组基础上联合rTMS治疗。比较两组治疗效果、不良反应... 目的分析重复经颅磁刺激(r TMS)联合西酞普兰治疗老年抑郁症的临床疗效。方法120例老年抑郁症患者为研究对象,随机分为观察组与对照组,各60例。对照组采用西酞普兰治疗,观察组在对照组基础上联合rTMS治疗。比较两组治疗效果、不良反应发生情况及治疗前后抑郁情况。结果观察组治疗总有效率95.00%高于对照组的75.00%,差异有统计学意义(P<0.05)。两组不良反应发生率比较,差异无统计学意义(P>0.05)。治疗2、4周,两组汉密尔顿抑郁量表(HAMD)评分均低于本组治疗前,且观察组HAMD评分分别为(18.20±4.50)、(14.50±2.50)分,均低于对照组的(23.20±5.60)、(20.02±3.50)分,差异均有统计学意义(P<0.05)。结论rTMS联合西酞普兰治疗老年抑郁症具有安全性、有效性,促进患者抑郁症状改善。 展开更多
关键词 重复经颅磁刺激 西酞普兰 老年抑郁症 治疗效果 不良反应 病情状况
下载PDF
USE OF CELL-BASED BIOASSAY FOR THE QUALITY CONTROL OF BOTANICAL THERAPEUTICS
13
作者 Doo Suk Lee Min-Jung Bae Sunyoung Kim 《World Journal of Traditional Chinese Medicine》 2015年第4期91-91,共1页
The single most important factor in modernization efforts of traditional oriental medicines is the limited understanding of active compounds responsible for claimed therapeutic effects.Indeed,the unknown identity of b... The single most important factor in modernization efforts of traditional oriental medicines is the limited understanding of active compounds responsible for claimed therapeutic effects.Indeed,the unknown identity of biologically active molecules generates major difficulties associated with botanical therapeutics in general.This includes management of raw materials,poor understanding of 展开更多
关键词 use OF CELL-BASED BIOASSAY FOR THE QUALITY CONTROL OF BOTANICAL therapeuticS PG
原文传递
国产西酞普兰联用多塞平治疗广泛性焦虑障碍的开放性研究 被引量:2
14
作者 童建明 刘成文 杨正春 《中国临床药理学与治疗学》 CAS CSCD 2008年第8期913-917,共5页
目的:通过国产西酞普兰和多塞平低剂量联用的开放性治疗,探讨其对广泛性焦虑障碍(GAD)的效果及安全性。方法:以西酞普兰20mg/d[原服有选择性5-羟色胺(5-HT)再回收抑制剂者药物及剂量保持不变]加用多塞平(75-125mg/d),并与同期... 目的:通过国产西酞普兰和多塞平低剂量联用的开放性治疗,探讨其对广泛性焦虑障碍(GAD)的效果及安全性。方法:以西酞普兰20mg/d[原服有选择性5-羟色胺(5-HT)再回收抑制剂者药物及剂量保持不变]加用多塞平(75-125mg/d),并与同期志愿接受文拉法辛治疗者对照比较。选择Hamilton焦虑量表(HAMA)评定治疗前,治疗后1、2、4、6周分值变化,以基线减分率评定6周治疗效果,副反应量表(TESS)评定治疗过程中的不良反应发生率。结果:两组完成6周治疗者50例和30例,脱落率分别为10.7%和9.1%,P=0.70,6周基线减分率差异均无统计学意义;有效率分别为92.0%、93.3%,P=0.83,两法效果差异经Ridit值比较也无统计学意义。HA-MA评定中,精神性焦虑因子减分差值在4-6周时有重要统计学意义。靶症状结合因子减分差值分析中,联用组的失眠、记忆/注意障碍和呼吸系统症状在4-6周时较文拉法辛组改善更为明显(P〈0.05-0.01)。不良反应中按SS集分析,联用组有较高的口干、便秘及体重增加现象。结论:西酞普兰等选择性5-HT再回收抑制类药物与抑制NE再摄取作用的多塞平联用对GAD显示出与SNRIS相同的效果,且安全性较高。因治疗成本不足文拉法辛的1/3,对低收入病员群体是一种更为实际的治疗方法。 展开更多
关键词 广泛性焦虑障碍 西酞普兰 多塞平 联合治疗
下载PDF
西酞普兰联合心理干预对乳腺癌患者心理健康状况及细胞免疫的影响 被引量:7
15
作者 李丽 王卿峰 +2 位作者 付培彪 王珍珍 陈瑞霞 《实用肿瘤杂志》 CAS 2019年第3期257-260,共4页
目的探讨西酞普兰联合心理干预对乳腺癌患者心理状况与细胞免疫的影响,验证心理因素与乳腺癌细胞免疫的关系。方法收集96例乳腺癌患者,采用症状自评量表评分,96例患者中40例高于抑郁因子上限(抑郁组),32例高于焦虑因子上限(焦虑组),其中... 目的探讨西酞普兰联合心理干预对乳腺癌患者心理状况与细胞免疫的影响,验证心理因素与乳腺癌细胞免疫的关系。方法收集96例乳腺癌患者,采用症状自评量表评分,96例患者中40例高于抑郁因子上限(抑郁组),32例高于焦虑因子上限(焦虑组),其中8例同时存在抑郁与焦虑(并入焦虑组)。将抑郁、焦虑患者分别随机抽样分为4组:对照组、药物组(西酞普兰片20 mg/d)、心理干预组(CBT为主的心理干预,约40 min/次,2次/周,共8次)和联合组(药物联合心理干预),每组各10例。连续治疗4周。治疗前及治疗后测试所有患者抑郁自评量表评分(self-rating depression scale,SDS)、焦虑自评量表(self-rating anxiety scale,SAS)评分及T细胞亚群+自然杀伤(natural killer,NK)细胞活性。结果抑郁、焦虑患者心理干预组、药物组和联合组治疗后SDS和SAS评分均降低(均P<0.05)。抑郁患者干预组(药物组+心理干预组+联合组)治疗后CD4^+/CD8^+比值和NK细胞活性均升高,焦虑患者干预组治疗后CD3^+细胞活性、CD4^+/CD8^+比值和NK细胞活性均升高(均P<0.05)。结论乳腺癌患者心理健康状况与细胞免疫功能相关,西酞普兰、心理干预或二者联合对于患者的抑郁、焦虑状态及免疫功能有一定的改善作用。 展开更多
关键词 乳腺肿瘤/心理学 西酞普兰/治疗应用 T淋巴细胞/生理学 杀伤细胞 天然/生理学 焦虑/治疗 抑郁/治疗 心理疗法 综合疗法 干预性研究
下载PDF
西酞普兰和阿米替林治疗抑郁症的对照研究 被引量:1
16
作者 王秀娟 王金童 +1 位作者 张跃琴 马洁 《天津药学》 2004年第3期34-35,39,共3页
目的 :比较西酞普兰和阿米替林治疗抑郁症的疗效和安全性。方法 :将 6 0例抑郁症患者随机分成两组 ,分别服用西酞普兰和阿米替林 ,疗程 8周。用汉密尔顿抑郁量表 (HAMD)和药物副反应量表 (TESS)评价 ,比较两种药物的疗效和安全性。结果 ... 目的 :比较西酞普兰和阿米替林治疗抑郁症的疗效和安全性。方法 :将 6 0例抑郁症患者随机分成两组 ,分别服用西酞普兰和阿米替林 ,疗程 8周。用汉密尔顿抑郁量表 (HAMD)和药物副反应量表 (TESS)评价 ,比较两种药物的疗效和安全性。结果 :西酞普兰治疗抑郁症的疗效和阿米替林相似 ,但副反应明显较后者少 (P <0 .0 5 )。结论 :西酞普兰是一种安全有效的抗抑郁药。 展开更多
关键词 西酞普兰 阿米替林 抑郁症 疗效 安全性
下载PDF
西酞普兰治疗苯二氮类药物依赖的对照研究 被引量:2
17
作者 陈巧平 司徒鹏 +3 位作者 李华静 丁猛 饶文霖 詹潮勇 《中国误诊学杂志》 CAS 2006年第9期1627-1629,共3页
目的:探讨西酞普兰对苯二氮艹卓类药物依赖的治疗效果及药物的不良反应。方法:对122例诊断为苯二氮艹卓类药物依赖的患者,随机分为治疗组(61例)和对照组(61例),治疗组给予西酞普兰,对照组给予多虑平,治疗12周。在治疗中定期分别给予汉... 目的:探讨西酞普兰对苯二氮艹卓类药物依赖的治疗效果及药物的不良反应。方法:对122例诊断为苯二氮艹卓类药物依赖的患者,随机分为治疗组(61例)和对照组(61例),治疗组给予西酞普兰,对照组给予多虑平,治疗12周。在治疗中定期分别给予汉密尔顿焦虑量表(HAM A)和副反应量表(TESS)评定疗效和不良反应。结果:两种药物的疗效相当,西酞普兰不良反应和减药反应少而轻。结论:西酞普兰对苯二氮艹卓类药物依赖的治疗疗效好,副反应轻,患者服药依从性好。西酞普兰是治疗苯二氮艹卓类药物成瘾安全有效的药物。 展开更多
关键词 西酞普兰/治疗应用 苯二氮(艹卓)类/副作用 物质相关性障碍/药物疗法
下载PDF
维生素B_6与艾司西酞普兰配伍治疗抑郁症45例临床研究 被引量:3
18
作者 王立娜 《陕西医学杂志》 CAS 2012年第1期85-87,共3页
目的:探讨维生素B6与艾司西酞普兰配伍治疗抑郁症的临床效果。方法:将90例抑郁症患者随机分为两组,每组45例。两组均给予艾司西酞普兰治疗,研究组在此基础上给予维生素B6治疗,疗程8周。并于治疗前及治疗第2、4、8周末采用汉密顿抑郁量... 目的:探讨维生素B6与艾司西酞普兰配伍治疗抑郁症的临床效果。方法:将90例抑郁症患者随机分为两组,每组45例。两组均给予艾司西酞普兰治疗,研究组在此基础上给予维生素B6治疗,疗程8周。并于治疗前及治疗第2、4、8周末采用汉密顿抑郁量表和抑郁症状学记录(临床医师评估)QIDS-C16评定临床状学记录。结果:两组治疗第2周末疗效相当(P>0.05);第4、8周末研究组汉密顿抑郁量表评分和抑郁症状学记录较对照组显著下降(P<0.05)。结论:艾司西酞普兰联合维生素B6治疗抑郁症较单用艾司西酞普兰疗效显著。 展开更多
关键词 抑郁症/药物疗法 维生素B6/治疗应用 西酞普兰/治疗应用
下载PDF
帕罗西汀联合西酞普兰治疗产后抑郁的疗效观察
19
作者 祁青玲 王烈宏 《中国医学前沿杂志(电子版)》 2020年第2期58-61,共4页
目的探讨帕罗西汀联合西酞普兰治疗产后抑郁的疗效。方法选取2017年1月至2019年6月青海红十字医院收治的产后抑郁患者92例,根据治疗方法的不同将入选患者均分为两组,联合治疗组患者46例,给予帕罗西汀联合西酞普兰治疗,对照组患者46例,... 目的探讨帕罗西汀联合西酞普兰治疗产后抑郁的疗效。方法选取2017年1月至2019年6月青海红十字医院收治的产后抑郁患者92例,根据治疗方法的不同将入选患者均分为两组,联合治疗组患者46例,给予帕罗西汀联合西酞普兰治疗,对照组患者46例,给予单纯帕罗西汀治疗。比较两组患者治疗前和治疗6周后爱丁堡产后抑郁量表(Edinburgh postnatal depression scale,EPDS)、汉密顿抑郁量表(Hamilton depression scale,HAMD)、抑郁自评量表(self-rating depression scale,SDS)评分和血清白介素-6(interleukin-6,IL-6)、白介素-1β(interleukin-1β,IL-1β)、肿瘤坏死因子-α(tumor necrosis factor-α,TNF-α)水平;比较两组患者治疗6周后的疗效和不良反应发生情况。结果治疗6周后,两组患者EPDS、HAMD、SDS评分以及血清IL-6、IL-1β及TNF-α水平均显著低于治疗前(均P<0.01),且联合治疗组患者以上指标均显著低于对照组(均P<0.01);联合治疗组患者疗效显著高于对照组(P=0.041);联合治疗组患者不良反应总发生率显著低于对照组(P=0.036)。结论帕罗西汀联合西酞普兰能够提高产后抑郁的治疗效果,减轻患者抑郁症状和机体炎性反应,且联合用药不良反应发生率低,安全性较高。 展开更多
关键词 帕罗西汀 西酞普兰 产后抑郁 炎性因子 疗效
下载PDF
Combination of "low-dose" ribavirin and interferon alfa-2a therapy followed by interferon alfa-2a monotherapy in chronic HCV-infected nonresponders and relapsers after interferon alfa-2a monotherapy 被引量:19
20
作者 Perdita Wietzke-Braun Volker Meier +1 位作者 Felix Braun Giuliano Ramadori 《World Journal of Gastroenterology》 SCIE CAS CSCD 2001年第2期222-227,共6页
AIM To report on the efficacy, safety and tolerability of interferon alfa-2a combined with a "low dose" of ribavirin for relapsers and non responders to alpha interferon monotherapy.METHODS Thirty-four chron... AIM To report on the efficacy, safety and tolerability of interferon alfa-2a combined with a "low dose" of ribavirin for relapsers and non responders to alpha interferon monotherapy.METHODS Thirty-four chronic hepatitis C virus-infected non-responders to interferon alfa2a monotherapy (a course of at least 3 months treatment) and 13 relapsers to interferon alfa 2a monotherapy (a dose of 3 to 6 million units three times per week for at least 20 weeks but not more than 18 months) were treated with the same dose of interferon alfa-2a used before (3 to 6 million units three times per week) and ribavirin (10 mg/ kg daily) for 6 months. In complete responders, interferon alfa-2a was administered for further 6 months at the same dose used before as monotherapy.RESULTS Seven (20.6%) of 34 non-responders stopped the combined therapy due to adverse events, including two patients with histological and clinical Child A cirrhosis. In 17/27 (63%)non-responders, the combined therapy was stopped after three months because of non-response. Ten of the 27 non-responders completed the 1;2-month treatment course. At a mean follow up of 28 months (16- 37 months)after the treatment, 4/10 (15%) previous non-responders still remained complete responders,All 13 previous relapsers completed the 12-month treatment course. At a mean follow up of 22months (9 - 36 months) after treatment, 6/13(46%) the previous relapsers were stillsustained complete responders.CONCLUSION Our treatment schedule of the combined therapy for 6 months of interferon alfa2a with a low dose of ribavirin (10 mg/kg/day)followed by 6 months of interferon alfa-2amonotherapy is able to induce a sustainedcomplete response rate in 15% of non-responders and 46% of relapsers with chronic hepatitis C virus-related liver diseases comparable to those obtained with the standarddoses of ribavirin 1000 - 1200 mg/day.Randomized prospective controlled trials using lower total amounts of ribavirin in combination with interferon should be performed. 展开更多
关键词 hepatitis C chronic/drug therapy INTERFERON alpha-2a/therapeutic use INTERFERON alpha-2a/administration & DOSAGE ribavirin/administration & DOSAGE ribavirin/therapeutic use
下载PDF
上一页 1 2 3 下一页 到第
使用帮助 返回顶部